VMAT1 (SLC18A1) (NM_001142325) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC227957L1V

  • LentiORF®

Lenti ORF particles, SLC18A1 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 1 (SLC18A1), transcript variant 4, 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP

Lentiviral Particles: DDK DDK w/ Puro mGFP mGFP w/ Puro

AAV Particle: DDK


Biosafety Sheet

USD 1,007.00

2 Weeks*

Size
    • 200 ul

Product Images

Frequently bought together (3)
Lenti ORF control particles of pLenti-C-Myc-DDK, >10^7 TU/mL, 0.5 mL
    • 500 ul

USD 365.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

USD 671.00


Anti-SLC18A1 Rabbit Polyclonal Antibody
    • 100 ul

USD 380.00

Other products for "VMAT1"

Specifications

Product Data
Type Human Tagged ORF Clone Lentiviral Particle
Tag Myc-DDK
Symbol VMAT1
Synonyms CGAT; VAT1; VMAT1
Mammalian Cell Selection None
Vector pLenti-C-Myc-DDK
ACCN NM_001142325
ORF Size 1416 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC227957).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_001142325.1, NP_001135797.1
RefSeq ORF 1419 bp
Locus ID 6570
UniProt ID P54219
Cytogenetics 8p21.3
Protein Families Transmembrane
Protein Pathways Parkinson's disease
MW 49.8 kDa
Gene Summary The vesicular monoamine transporter acts to accumulate cytosolic monoamines into vesicles, using the proton gradient maintained across the vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (Peter et al., 1993 [PubMed 7905859]). See also SLC18A2 (MIM 193001).[supplied by OMIM, Mar 2008]

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.